Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ALT holding history

Altimmune, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALT overviewAll 13F holders of ALTFull Q2 2026 holdings

Shares (Q2 2026)
201,638
Value
$613.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ALT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026201,638$613.0K<0.1%−525,363−72.3%ReducedHolders
Q1 2026727,001$2.24M<0.1%−616,582−45.9%ReducedHolders
Q4 20251,343,583$4.85M<0.1%+983,188+272.8%AddedHolders
Q3 2025360,395$1.36M<0.1%+309,137+603.1%AddedHolders
Q2 202551,258$198.4K<0.1%+742+1.5%AddedHolders
Q1 202550,516$252.6K<0.1%−409,317−89.0%ReducedHolders
Q4 2024459,833$3.32M<0.1%−298,171−39.3%ReducedHolders
Q3 2024758,004$4.65M<0.1%−4,358−0.6%ReducedHolders
Q2 2024762,362$5.07M<0.1%+408,012+115.1%AddedHolders
Q1 2024354,350$3.61M<0.1%+64,624+22.3%AddedHolders
Q4 2023289,726$3.26M<0.1%−441,006−60.4%ReducedHolders
Q3 2023730,732$1.90M<0.1%+226,494+44.9%AddedHolders
Q2 2023504,238$1.78M<0.1%+504,238NewHolders
Q1 20230$00.0%−27,702−100.0%Sold outHolders
Q4 202227,702$455.7K<0.1%+27,702NewHolders
Q3 20220$00.0%−169,683−100.0%Sold outHolders
Q2 2022169,683$1.99M<0.1%−798,053−82.5%ReducedHolders
Q1 2022967,736$5.89M<0.1%−213,501−18.1%ReducedHolders
Q4 20211,181,237$10.8M<0.1%+225,799+23.6%AddedHolders
Q3 2021955,438$10.8M<0.1%+127,682+15.4%AddedHolders
Q2 2021827,756$8.15M<0.1%−488,058−37.1%ReducedHolders
Q1 20211,315,814$18.6M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.